Esoglaz-D Capsule PR
Images are for reference. Actual packaging may vary.
Domperidone (30mg) + Esomeprazole (40mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Domperidone antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, inhibiting nausea and vomiting.
Esomeprazole irreversibly inhibits the H+/K+ ATPase enzyme in the gastric parietal cells, reducing gastric acid secretion.
Medical applications
Esoglaz-D Capsule PR is a combination pharmaceutical formulation containing Domperidone 30 mg and Esomeprazole 40 mg, designed to manage gastrointestinal disorders associated with acid reflux and motility disturbances. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by accelerating gastric emptying and improving esophageal sphincter tone, thereby reducing symptoms such as nausea, vomiting, and bloating.
Esomeprazole, a proton pump inhibitor (PPI), selectively inhibits the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, effectively suppressing gastric acid secretion. This dual-action capsule is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and conditions requiring acid suppression combined with prokinetic activity.
The prolonged-release formulation ensures sustained therapeutic plasma levels, improving patient compliance and symptom control. Esoglaz-D Capsule PR should be administered as prescribed, typically once daily before meals, and is contraindicated in patients with known hypersensitivity to either component or in those with prolactin-releasing pituitary tumors. Caution is advised in patients with hepatic impairment or cardiac arrhythmias.
Potential adverse effects include headache, dry mouth, abdominal discomfort, and, rarely, extrapyramidal symptoms. Regular monitoring and consultation with a healthcare professional are recommended during therapy.
How to use Esoglaz-D Capsule PR Use it as advised by your doctor or check the label for directions before use. Esoglaz-D Capsule PR is to be taken empty stomach.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Caution is advised when consuming alcohol with Esoglaz-D Capsule PR. Please consult your doctor.
High Risk
Esoglaz-D Capsule PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Esoglaz-D Capsule PR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Esoglaz-D Capsule PR is safe to use in patients with liver disease. No dose adjustment of Esoglaz-D Capsule PR is recommended.
Regular Checkup
Esoglaz-D Capsule PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Esoglaz-D Capsule PR should be used with caution in patients with severe kidney disease. Dose adjustment of Esoglaz-D Capsule PR may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Esoglaz-D Capsule PR







